Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Ventilator-associated pneumonia and bloodstream infections in intensive care unit cancer patients: a retrospective 12-year study on 3388 prospectively monitored patients.

Stoclin A, Rotolo F, Hicheri Y, Mons M, Chachaty E, Gachot B, Pignon JP, Wartelle M, Blot F.

Support Care Cancer. 2019 Apr 17. doi: 10.1007/s00520-019-04800-6. [Epub ahead of print]

PMID:
31001694
2.

DNMT3A mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia.

Bond J, Touzart A, Leprêtre S, Graux C, Bargetzi M, Lhermitte L, Hypolite G, Leguay T, Hicheri Y, Guillerm G, Bilger K, Lhéritier V, Hunault M, Huguet F, Chalandon Y, Ifrah N, Macintyre E, Dombret H, Asnafi V, Boissel N.

Haematologica. 2019 Aug;104(8):1617-1625. doi: 10.3324/haematol.2018.197848. Epub 2019 Jan 17.

3.

[Post-transplant pulmonary complications: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].

Buchbinder N, Wallyn F, Lhuillier E, Hicheri Y, Magro L, Farah B, Cornillon J, Duléry R, Vincent L, Brissot E, Yakoub-Agha I, Chevallier P.

Bull Cancer. 2019 Jan;106(1S):S10-S17. doi: 10.1016/j.bulcan.2018.11.006. Epub 2018 Dec 27. French.

PMID:
30595221
4.

[Post-transplant neurological complications: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].

Hicheri Y, Buchbinder N, Magro L, Farah B, Zephir H, Brissot E, Yakoub-Agha I, Chevallier P.

Bull Cancer. 2019 Jan;106(1S):S18-S22. doi: 10.1016/j.bulcan.2018.08.015. Epub 2018 Nov 2. French.

PMID:
30392709
5.

Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC.

Malard F, Labopin M, Cho C, Blaise D, Papadopoulos EB, Passweg J, O'Reilly R, Forcade E, Maloy M, Volin L, Castro-Malaspina H, Hicheri Y, Jakubowski AA, Orvain C, Giralt S, Mohty M, Nagler A, Perales MA.

J Hematol Oncol. 2018 Oct 20;11(1):127. doi: 10.1186/s13045-018-0668-3.

6.

Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors.

Sanchez-Martinez D, Allende-Vega N, Orecchioni S, Talarico G, Cornillon A, Vo DN, Rene C, Lu ZY, Krzywinska E, Anel A, Galvez EM, Pardo J, Robert B, Martineau P, Hicheri Y, Bertolini F, Cartron G, Villalba M.

Theranostics. 2018 Jun 14;8(14):3856-3869. doi: 10.7150/thno.25149. eCollection 2018.

7.

Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Heinicke T, Labopin M, Schmid C, Polge E, Socié G, Blaise D, Mufti GJ, Huynh A, Brecht A, Ledoux MP, Cahn JY, Milpied N, Scheid C, Hicheri Y, Mohty M, Savani BN, Nagler A.

Biol Blood Marrow Transplant. 2018 Nov;24(11):2224-2232. doi: 10.1016/j.bbmt.2018.07.007. Epub 2018 Aug 7.

PMID:
30009981
8.

Targeting the SUMO Pathway Primes All-trans Retinoic Acid-Induced Differentiation of Nonpromyelocytic Acute Myeloid Leukemias.

Baik H, Boulanger M, Hosseini M, Kowalczyk J, Zaghdoudi S, Salem T, Sarry JE, Hicheri Y, Cartron G, Piechaczyk M, Bossis G.

Cancer Res. 2018 May 15;78(10):2601-2613. doi: 10.1158/0008-5472.CAN-17-3361. Epub 2018 Feb 27.

9.

Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Decroocq J, Itzykson R, Vigouroux S, Michallet M, Yakoub-Agha I, Huynh A, Beckerich F, Suarez F, Chevallier P, Nguyen-Quoc S, Ledoux MP, Clement L, Hicheri Y, Guillerm G, Cornillon J, Contentin N, Carre M, Maillard N, Mercier M, Mohty M, Beguin Y, Bourhis JH, Charbonnier A, Dauriac C, Bay JO, Blaise D, Deconinck E, Jubert C, Raus N, Peffault de Latour R, Dhedin N.

Am J Hematol. 2018 Mar;93(3):416-423. doi: 10.1002/ajh.25004. Epub 2018 Jan 8.

10.

Tracking the spread routes of opportunistic premise plumbing pathogens in a haematology unit with water points-of-use protected by antimicrobial filters.

Baranovsky S, Jumas-Bilak E, Lotthé A, Marchandin H, Parer S, Hicheri Y, Romano-Bertrand S.

J Hosp Infect. 2018 Jan;98(1):53-59. doi: 10.1016/j.jhin.2017.07.028. Epub 2017 Jul 29.

PMID:
28760634
11.

Cytomegalovirus Infection With Retinitis After Brentuximab Vedotin Treatment for CD30+ Lymphoma.

Tudesq JJ, Vincent L, Lebrun J, Hicheri Y, Gabellier L, Busetto T, Merle C, Fegueux N, Ceballos P, Quittet P, Navarro R, Hillaire-Buys D, Cartron G.

Open Forum Infect Dis. 2017 Apr 5;4(2):ofx091. doi: 10.1093/ofid/ofx091. eCollection 2017 Spring.

12.

Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemia.

Cahu X, Carré M, Recher C, Pigneux A, Hunault-Berger M, Vey N, Chevallier P, Delaunay J, Gyan E, Lioure B, Bonmati C, Himberlin C, Hicheri Y, Guillerm G, Didier B, Larosa F, Ojeda-Uribe M, Bernard M, Bene MC, Ifrah N, Cahn JY.

Eur J Haematol. 2017 May;98(5):443-449. doi: 10.1111/ejh.12850. Epub 2017 Mar 1.

PMID:
28122150
13.

CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity.

Krzywinska E, Cornillon A, Allende-Vega N, Vo DN, Rene C, Lu ZY, Pasero C, Olive D, Fegueux N, Ceballos P, Hicheri Y, Sobecki M, Rossi JF, Cartron G, Villalba M.

PLoS One. 2016 Apr 21;11(4):e0150434. doi: 10.1371/journal.pone.0150434. eCollection 2016.

14.

Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers.

Krzywinska E, Allende-Vega N, Cornillon A, Vo DN, Cayrefourcq L, Panabieres C, Vilches C, Déchanet-Merville J, Hicheri Y, Rossi JF, Cartron G, Villalba M.

EBioMedicine. 2015 Aug 13;2(10):1364-76. doi: 10.1016/j.ebiom.2015.08.021. eCollection 2015 Oct.

15.

The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism.

Allende-Vega N, Krzywinska E, Orecchioni S, Lopez-Royuela N, Reggiani F, Talarico G, Rossi JF, Rossignol R, Hicheri Y, Cartron G, Bertolini F, Villalba M.

Oncotarget. 2015 Aug 7;6(22):19228-45.

16.

Effect of graft source on unrelated donor hemopoietic stem cell transplantation in adults with acute myeloid leukemia after reduced-intensity or nonmyeloablative conditioning: a study from the Société Francaise de Greffe de Moelle et de Thérapie Cellulaire.

Malard F, Milpied N, Blaise D, Chevallier P, Michallet M, Lioure B, Clément L, Hicheri Y, Cordonnier C, Huynh A, Yakoub-Agha I, Peffault de Latour R, Mohty M.

Biol Blood Marrow Transplant. 2015 Jun;21(6):1059-67. doi: 10.1016/j.bbmt.2015.02.014. Epub 2015 Feb 20.

17.

[Kinetic and organization of granulocytes transfusion: a case report].

Lamure S, Latry P, Kanouni T, Hicheri Y, Sirvent A, Lenglet A, Mathieu-Daude D, Cazal P, Cartron G.

Transfus Clin Biol. 2014 Dec;21(6):324-7. doi: 10.1016/j.tracli.2014.09.005. Epub 2014 Nov 6. French.

PMID:
25441453
18.

Quality controls on cord blood unit contiguous segments: recommendation of the SFGM-TC.

De Vos J, Birebent B, Faucher C, Giet O, Hicheri Y, Lemarie C, Baudoux E, Boulanger F, Garnier F, Larghero J, Pouthier F, Thibert JB, Yakoub-Agha I; SFGM-TC.

Pathol Biol (Paris). 2014 Aug;62(4):218-20. doi: 10.1016/j.patbio.2014.05.005. Epub 2014 Jul 1.

19.

[Hematopoietic Stem Cell Transplantation using unrelated cord blood: which unit to choose? A report of the SFGM-TC].

Michel G, Detrait M, Elsermans V, Faucher C, Hicheri Y, Ivanova-Derin R, Lemarie C, Sirvent A, Top I, Garnier F, Boulanger F, Michallet M, Yakoub-Agha I; SFGM-TC.

Pathol Biol (Paris). 2013 Aug;61(4):147-8. doi: 10.1016/j.patbio.2013.07.007. Epub 2013 Sep 4. French.

PMID:
24011969
20.

[Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report].

Bay JO, Peffault de Latour R, Bruno B, Coiteux V, Guillaume T, Hicheri Y, Paillard C, Suarez F, Turlure P, Alain S, Bulabois CE, Socié G, Bauters F, Yakoub-Agha I; SFGM-TC.

Pathol Biol (Paris). 2013 Aug;61(4):152-4. doi: 10.1016/j.patbio.2013.07.003. Epub 2013 Sep 4. French.

PMID:
24011961
21.

Environmental prevention of infection in stem cell transplant recipients: a survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

Hicheri Y, Einsele H, Martino R, Cesaro S, Ljungman P, Cordonnier C.

Transpl Infect Dis. 2013 Jun;15(3):251-8. doi: 10.1111/tid.12064. Epub 2013 Mar 6.

PMID:
23465046
22.

A new workflow for the microbiological diagnosis of febrile neutropenia in patients with a central venous catheter.

Pautas C, Sbidian E, Hicheri Y, Bastuji-Garin S, Bretagne S, Corbel C, Gregoire L, Maury S, Merabet L, Cordonnier C, Cambau E.

J Antimicrob Chemother. 2013 Apr;68(4):943-6. doi: 10.1093/jac/dks462. Epub 2012 Nov 21.

PMID:
23171951
23.

Antifungal prophylaxis in haematology patients: the role of voriconazole.

Hicheri Y, Cook G, Cordonnier C.

Clin Microbiol Infect. 2012 Apr;18 Suppl 2:1-15. doi: 10.1111/j.1469-0691.2012.03772.x. Review.

24.

Hemophagocytic syndrome after allogeneic hematopoietic cell transplantation: more a graft rejection than an infectious process?

Redjoul R, Toma A, Hicheri Y, El Maaroufi H, Maertens J, Vigouroux S, Lioure B, Machaczka M, Pautas C, Bories D, Wagner-Ballon O, Gaulard P, Martin-Garcia N, Maury S, Cordonnier C.

Eur J Haematol. 2012 May;88(5):458-60. doi: 10.1111/j.1600-0609.2012.01757.x. Epub 2012 Feb 14. No abstract available.

PMID:
22268532
25.

Is there still a place for myeloablative regimen to transplant young adults with sickle cell disease?

Kuentz M, Robin M, Dhedin N, Hicheri Y, Peffault de Latour R, Rohrlich P, Bordigoni P, Bruno B, Socié G, Bernaudin F.

Blood. 2011 Oct 20;118(16):4491-2; author reply 4492-3. doi: 10.1182/blood-2011-07-367490. No abstract available.

26.

Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 study.

Thomas X, Elhamri M, Raffoux E, Renneville A, Pautas C, de Botton S, de Revel T, Reman O, Terré C, Gardin C, Chelghoum Y, Boissel N, Quesnel B, Hicheri Y, Bourhis JH, Fenaux P, Preudhomme C, Michallet M, Castaigne S, Dombret H.

Blood. 2011 Aug 18;118(7):1754-62. doi: 10.1182/blood-2011-04-349258. Epub 2011 Jun 20.

27.

Clofarabine as a potential stimulant of alloreactivity.

Atimere N, Zriba S, Hicheri Y, Pautas C, Cordonnier C, Maury S.

Bone Marrow Transplant. 2011 Oct;46(10):1393-4. doi: 10.1038/bmt.2010.309. Epub 2010 Dec 13. No abstract available.

PMID:
21151182
28.

Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.

Alanio A, Sitterlé E, Liance M, Farrugia C, Foulet F, Botterel F, Hicheri Y, Cordonnier C, Costa JM, Bretagne S.

J Antimicrob Chemother. 2011 Feb;66(2):371-4. doi: 10.1093/jac/dkq450. Epub 2010 Dec 5.

PMID:
21131690
29.

Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study.

Even C, Bastuji-Garin S, Hicheri Y, Pautas C, Botterel F, Maury S, Cabanne L, Bretagne S, Cordonnier C.

Haematologica. 2011 Feb;96(2):337-41. doi: 10.3324/haematol.2010.030825. Epub 2010 Nov 11.

30.

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire.

Mohty M, Labopin M, Balère ML, Socié G, Milpied N, Tabrizi R, Ifrah N, Hicheri Y, Dhedin N, Michallet M, Buzyn A, Cahn JY, Bourhis JH, Blaise D, Raffoux C, Espérou H, Yakoub-Agha I.

Leukemia. 2010 Nov;24(11):1867-74. doi: 10.1038/leu.2010.200. Epub 2010 Sep 30.

PMID:
20882046
31.

Updated guidelines for managing fungal diseases in hematology patients.

Hicheri Y, Toma A, Maury S, Pautas C, Mallek-Kaci H, Cordonnier C.

Expert Rev Anti Infect Ther. 2010 Sep;8(9):1049-60. doi: 10.1586/eri.10.85. Review.

PMID:
20818948
32.

CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation.

Maury S, Lemoine FM, Hicheri Y, Rosenzwajg M, Badoual C, Cheraï M, Beaumont JL, Azar N, Dhedin N, Sirvent A, Buzyn A, Rubio MT, Vigouroux S, Montagne O, Bories D, Roudot-Thoraval F, Vernant JP, Cordonnier C, Klatzmann D, Cohen JL.

Sci Transl Med. 2010 Jul 21;2(41):41ra52. doi: 10.1126/scitranslmed.3001302.

33.

Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myelodysplasies.

Kelaidi C, Stamatoullas A, Beyne-Rauzy O, Raffoux E, Quesnel B, Guerci A, Dreyfus F, Brechignac S, Berthou C, Prebet T, Hicheri Y, Hacini M, Delaunay J, Gourin MP, Camo JM, Zerazhi H, Taksin AL, Legros L, Choufi B, Fenaux P; Groupe Francophone des Myélodysplasies.

Haematologica. 2010 Jun;95(6):892-9. doi: 10.3324/haematol.2009.014357. Epub 2009 Dec 16.

34.

The epidemiology of invasive Streptococcus pneumoniae infections in onco-haematology and haematopoietic stem cell transplant patients in France. Are the serotypes covered by the available anti-pneumococcal vaccines?

Debbache K, Varon E, Hicheri Y, Legrand P, Donay JL, Ribaud P, Cordonnier C.

Clin Microbiol Infect. 2009 Sep;15(9):865-8. doi: 10.1111/j.1469-0691.2009.02810.x. Epub 2009 Jun 22.

35.

Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis.

Cordonnier C, Botterel F, Ben Amor R, Pautas C, Maury S, Kuentz M, Hicheri Y, Bastuji-Garin S, Bretagne S.

Clin Microbiol Infect. 2009 Jan;15(1):81-6. doi: 10.1111/j.1469-0691.2008.02122.x. Epub 2008 Dec 20.

36.

Scedosporium prolificans: an emerging pathogen in France?

Grenouillet F, Botterel F, Crouzet J, Larosa F, Hicheri Y, Forel JM, Helias P, Ranque S, Delhaes L.

Med Mycol. 2009 Jun;47(4):343-50. doi: 10.1080/13693780802454761. Epub 2008 Dec 12. Review.

PMID:
19085456
37.

Donor regulatory T cells identified by FoxP3 expression but also by the membranous CD4+CD127low/neg phenotype influence graft-versus-tumor effect after donor lymphocyte infusion.

Hicheri Y, Bouchekioua A, Hamel Y, Henry A, Rouard H, Pautas C, Beaumont JL, Kuentz M, Cordonnier C, Cohen JL, Maury S.

J Immunother. 2008 Nov-Dec;31(9):806-11. doi: 10.1097/CJI.0b013e318184908d.

PMID:
18833007
38.

Successful non-myeloablative allogeneic HLA-identical stem cell transplantation for CD4/CD56 positive acute leukemia.

Ben Amor R, Hicheri Y, Pautas C, Jouault H, Kuentz M, Cordonnier C, Maury S.

Transplantation. 2007 Oct 27;84(8):1066-7. No abstract available.

PMID:
17989617
39.

[ABO incompatibility and non myeloablative allogeneic stem cell transplantation].

Malfuson JV, Hicheri Y, Bonin P, Rodet M, Boccaccio C, Pautas C, Kuentz M, Cordonnier C, Noizat-Pirenne F, Maury S.

Transfus Clin Biol. 2007 Aug;14(3):327-33. Epub 2007 Apr 25. Review. French.

PMID:
17462938

Supplemental Content

Loading ...
Support Center